The emergency commissioner would have declared this in his meeting with the Regions, adding that 15 million doses will be delivered by March
–
The emergency commissioner would have declared this in his meeting with the Regions, adding that 15 million doses will be delivered by March
–
2 ‘of reading
The first delivery of the vaccine AstraZeneca, in case of green light from the EMA on January 29, it should arrive on February 15. This is what the Commissioner for the emergency Domenico Arcuri said during the meeting with the Regions, according to what Ansa learns. The other two deliveries would instead be scheduled for February 28 and March 15.
Arcuri also stated that approximately 15 million doses of vaccine, explaining that from Astrazeneca (if approved by Ema) we will receive 3.4 million doses against the 8 foreseen (although in the official government plan there are 16 million), in addition to those of Moderna and Pfizer.
Loading…
Distrusted to Pfizer and exposed to pm
The Commissioner confirmed the country’s intention to take legal action against delays in deliveries by the US group Pfizer. On Monday, the State Attorney’s Office will have completed the legal investigations and Italy will proceed against the US company on three channels: one formal notice for default to be presented in Italy, a exposed to pm for potential damage to health e a request on behalf of the government Italian and regions at the Brussels Bar for non-compliance.
Pfizer’s delay, coupled with that of AstraZeneca vaccines, is forcing the Italian government to review its objectives for the first phase of the vaccination campaign.
Boccia, coordination with regions Permanent coordination on vaccines
The Minister of Regional Affairs, Fracesco Bocci, would instead have proposed a permanent coordination between the State and the Regions “as long as the companies do not give definitive certainties” on the delivery of vaccines, asking everyone “maximum solidarity and institutional tones”. “We are convened – he added – for every update that Commissioner Arcuri will have to communicate on vaccines, distribution and discussions with pharmaceutical companies”.
–
